Literature DB >> 22336225

Prostacyclin receptor-dependent inhibition of human erythroleukemia cell differentiation is STAT3-dependent.

Alaster H Y Lau1, Henry K H Lai, Barry H S Yeung, Sze Lee Leung, Suk Ying Tsang, Yung H Wong, Helen Wise.   

Abstract

We have previously demonstrated that activation of prostacyclin (IP) receptors in human erythroleukemia (HEL) cells phosphorylates the signal transducer and activator of transcription 3 (STAT3) via Gα(s) and Gα(16) hybrid signalling. This current study was designed to determine if functional responses to cicaprost in HEL cells were dependent on STAT3 phosphorylation. Cicaprost significantly enhanced the rapid change in HEL cell morphology induced by phorbol-12-myristate-13-acetate (PMA), and this effect was inhibited by the IP receptor antagonist RO1138452 and a STAT3 inhibitory peptide. Other indicators of PMA-induced HEL cell differentiation, such as increased expression of CD41/CD61 and an increase in cell complexity/granularity, were inhibited by cicaprost in an IP receptor-dependent and STAT3-dependent manner. Although thrombopoietic cytokines promote megakaryocytic differentiation and platelet production via activation of STAT3, the predominant STAT3-dependent effects of cicaprost in HEL cells were inhibitory towards the process of PMA-induced megakaryocytopoeisis. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22336225     DOI: 10.1016/j.plefa.2011.12.002

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  2 in total

1.  The extracellular sulfatase SULF2 promotes liver tumorigenesis by stimulating assembly of a promoter-looping GLI1-STAT3 transcriptional complex.

Authors:  Ryan M Carr; Paola A Romecin Duran; Ezequiel J Tolosa; Chenchao Ma; Abdul M Oseini; Catherine D Moser; Bubu A Banini; Jianbo Huang; Faizal Asumda; Renumathy Dhanasekaran; Rondell P Graham; Merih D Toruner; Stephanie L Safgren; Luciana L Almada; Shaoqing Wang; Mrinal M Patnaik; Lewis R Roberts; Martin E Fernandez-Zapico
Journal:  J Biol Chem       Date:  2020-01-27       Impact factor: 5.157

2.  Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression.

Authors:  John Castle; Karen Morris; Susan Pritchard; Cliona C Kirwan
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.